Bio-Path Holdings Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall St set for lower open as Alphabet results reignite AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- Moderna stock rises on latest cancer vaccine data publication
Bio-Path Holdings (BPTH) Tops Q2 EPS by 8c
August 16, 2022 7:54 AM EDTBio-Path Holdings (NASDAQ: BPTH) reported Q2 EPS of ($0.42), $0.08 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.
... More


